EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design

S D Muthumaraswamy iD, M J Baggott, E E Schenberg, D Repantis, M Wolff, A Forsyth, T Noorani

Therapeutic Advances in Psychopharmacology · 2025-09 · 15

DOI: 10.1177/20451253251381074 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 02.10.2025. Verfasst von S D Muthumaraswamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: The University of Auckland, 85 Park Road, Auckland 1023, New Zealand. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelic-assisted therapy (PAT) has typically been evaluated using conventional randomised controlled trials (RCTs), which assess treatment efficacy under highly controlled conditions. However, PAT constitutes a complex intervention, integrating pharmacological, psychotherapeutic and contextual elements that interact dynamically with patient experiences and healthcare settings. Conventional RCTs, designed for simple interventions, may fail to capture these complexities. Pragmatic trials, by contrast, evaluate interventions under real-world conditions, assessing their effectiveness across diverse clinical environments and patient populations. This position paper advocates for the application of the UK Medical Research Council’s (MRC) framework for complex interventions to the development and evaluation of PAT. This framework emphasises the necessity of articulating the underlying theory of therapeutic change, structuring intervention development into defined phases, accounting for contextual interactions and incorporating stakeholder perspectives throughout the research process. We argue that employing pragmatic trial designs, guided by the PRECIS-2 tool, will better align PAT research with the practicalities of healthcare delivery and facilitate the translation of research findings into clinical practice. Further, we address the philosophical divergence in the field between conceptualising PAT as primarily pharmacological versus psychotherapy-augmented, noting the implications of these positions for trial design and interpretation. We propose the integration of qualitative methodologies, adaptive trial designs and comparative effectiveness research to refine PAT interventions and address limitations inherent in conventional double-blind RCT approaches. Finally, we advocate for a pluralistic evidentiary model, combining academic and community-led research, to support the rigorous, equitable and sustainable development of psychedelic-assisted therapies and to avoid the historical setbacks that previously hindered progress in this field.

Schlagwörter

Stichwörter der Autor:innen

clinical trial designclinical trialscomplex interventionspragmatic trialspsychedelic-assisted therapy

Autor:innen und Institutionen

  • The University of Auckland, 85 Park Road, Auckland 1023, New Zealand.
  • Tactogen Inc, Palo Alto, CA USA.
  • Instituto Phaneros, São Paulo, Brazil.
  • Language, Action and Brain Laboratory, University College London, London, UK.
  • Affiliated Researcher of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, MA, USA.
  • Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

ORCID-Profile: S D Muthumaraswamy

Zitieren

APA

Muthumaraswamy, S. D., Baggott, M. J., Schenberg, E. E., Repantis, D., Wolff, M., Forsyth, A., & Noorani, T. (2025). Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. Therapeutic Advances in Psychopharmacology, 15. https://doi.org/10.1177/20451253251381074

Vancouver

Muthumaraswamy SD, Baggott MJ, Schenberg EE, Repantis D, Wolff M, Forsyth A, et al. Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. Therapeutic Advances in Psychopharmacology. 2025;15. doi:10.1177/20451253251381074

BibTeX
@article{Muthumaraswamy2025,
  author = {Muthumaraswamy, S D and Baggott, M J and Schenberg, E E and Repantis, D and Wolff, M and Forsyth, A and Noorani, T},
  title = {Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2025},
  volume = {15},
  doi = {10.1177/20451253251381074}
}
Kostenlos starten →